5
Volume 3, Issue 1, May, 2023
A B O U T T H E
A U T H O R S
Amaris K. Balitsky, MD, MSc, FRCPC
Gwynivere A. Davies, MD, MPH, FRCPC
Dr. Balitsky is a malignant hematologist at Juravinski
Hospital and Cancer Centre, specializing in lymphoid
malignancies and cellular therapy. Her outcomes and
health services research focuses on patient-reported
outcomes, and short- and long-term toxicities of
therapy.
Affiliations:
Hamilton Health Sciences, Juravinski Cancer Centre,
Hamilton, ON
Department of Oncology, McMaster University, Hamilton,
ON
Dr. Davies is a practicing clinician-educator at McMaster
University, and focuses on lymphoma, autologous stem
cell transplant and CAR-T in her clinical practice at the
Juravinski Hospital and Cancer Centre. Her research
interests include the social determinants of health,
supported by her MPH from Harvard (2020), health
services research and education on the intrinsic roles in
the liminal space between residency and independent
practice.
Affiliations:
Hamilton Health Sciences, Juravinski Cancer Centre,
Hamilton, ON
Department of Oncology, McMaster University, Hamilton, ON
